Evidence that punctate intracerebral administration of 6-hydroxydopamine fails to produce selective neuronal degeneration. Comparison with copper sulfate and factors governing the deportment of fluids injected into brain

Naunyn Schmiedebergs Arch Pharmacol. 1974;285(1):31-70. doi: 10.1007/BF00499527.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Behavior, Animal / drug effects
  • Brain / anatomy & histology
  • Brain / enzymology
  • Brain / metabolism
  • Brain Chemistry / drug effects
  • Catecholamines / physiology
  • Cholinesterase Inhibitors / pharmacology
  • Copper / pharmacology*
  • Female
  • Hydroxydopamines / administration & dosage
  • Hydroxydopamines / pharmacology*
  • Injections
  • Myelin Sheath / analysis
  • NADH, NADPH Oxidoreductases / metabolism
  • Nerve Degeneration / drug effects*
  • Neurons / analysis
  • Putamen
  • Rats
  • Red Nucleus / anatomy & histology
  • Stereotaxic Techniques
  • Substantia Nigra
  • Sulfates / pharmacology
  • Tegmentum Mesencephali
  • Thalamus

Substances

  • Catecholamines
  • Cholinesterase Inhibitors
  • Hydroxydopamines
  • Sulfates
  • Copper
  • NADH, NADPH Oxidoreductases